Physica System Total Knee Replacement Registry Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age22+
SponsorLimacorporate S.p.a

About this trial

The primary objective of this study is to obtain long-term implant survivorship (out to 10 years) and to assess clinical, patient-reported outcome measures, and radiographic data for the commercially available Physica system. For ancillary arm, from baseline to 5-year follow-up.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Males and females of any race requiring a total knee replacement and suitable for the use of one of the configurations of the Physica system

Age> 22 (skeletally mature)

Suitable candidates for TKR who have undamaged and functional collateral ligaments

Suitable candidates for TKR with Physica KR, CR, who have an undamaged and functional posterior cruciate ligament; or Physica LMC with or without a functioning posterior cruciate ligament or Physica PS with an absent or not-functioning posterior cruciate ligament and/or severe antero-posterior instability of the knee joint

Disqualifiers

Patients with severe instability of the knee joint secondary to the absence of collateral ligament integrity and/or function

Patients with active or any suspected infection (on the affected knee or systemic)

Previous partial knee replacement (unicompartimental, bicompartimental or patellofemoral joint replacement), patellectomy, high tibial osteotomy

Patients with significant bone loss on femoral or tibial joint side

Trial design

Design model

Single group

Treatments tested in this trial

  • Physica Kinematic Retaining Knee System

    Device

    Modular total knee prosthesis with a Kinematic Retaining mechanism and posterior cruciate ligament (PCL) preservation

  • Physica Cruciate Retaining Knee System

    Device

    Total knee prosthesis with posterior cruciate ligament (PCL) preservation

  • Physica Posterior Stabilized Knee System

    Device

    Total knee prosthesis that sacrifices the posterior cruciate ligament (PCL) and replaces the functionality of the PCL with a post-cam mechanism.

  • Physica Cruciate Retaining Knee System with LMC Liner

    Device

    Total knee prosthesis with posterior cruciate ligament (PCL) preservation

Treatment groups

800 Participants
are divided into 4 treatment groups
Group A: Physica KROther 1 intervention
Group B: Physica CROther 1 intervention
Group C: Physica PSOther 1 intervention
Group D: Physica CR with LMC LinerOther 1 intervention

Trial outcomes

Primary outcomes

1

Implant Survivorship

The primary endpoint is the definition of the implant survivorship of the study device to 10 years after the total knee replacement surgery.

Time frame
10 years

Secondary outcomes

1

American Knee Society Score (KSS) 2011

Clinical performance assessment measured by overall pain and functionality from baseline to 10-year follow-up

Time frame
10 years
2

Patient-Reported Outcome Measures (PROMs)

Patient-Reported Outcome Measures (PROMs) including patient satisfaction achievement from baseline to 10-year follow-up

Time frame
10 years
3

Radiographic Evaluation

• Radiographic implant evaluation and stability assessment from baseline to 10-year follow-up

Time frame
10 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.